大麻二酚缓解LPS抑制的人牙髓干细胞成牙/成骨分化
本研究探讨大麻二酚(CBD)对人牙髓干细胞(hDPSC)增殖、凋亡、迁移及成牙/成骨分化的影响。在正常培养及牙龈卟啉单胞菌LPS诱导的炎症环境下,1.25 μg/mL CBD可显著逆转LPS对hDPSC增殖和成牙/成骨分化的抑制作用。蛋白组学和RNA测序提示CBD可能通过激活Notch信号通路发挥作用。
要点
- 1.25 μg/mL CBD可逆转LPS对hDPSC增殖和成牙/成骨分化的抑制。
- CBD可能通过激活Notch信号通路恢复炎症下hDPSC的成牙/成骨分化。
- CBD在正常条件下对hDPSC行为影响极小,提示其安全性。
核心结论
- CBD可恢复LPS暴露后hDPSC的增殖和存活。
- CBD介导的Notch激活可有效恢复炎症条件下hDPSC的成牙/成骨分化能力。
- 结果提示CBD可能作为促进牙本质再生的治疗选择。
研究设计与样本
- 体外研究,从人牙髓组织获取hDPSC。
- CBD浓度设置为1.25、2.5、5、10、25和50 μg/mL。
- 在正常培养条件和牙龈卟啉单胞菌LPS诱导的炎症环境下评估细胞反应。
- 采用RNA测序和蛋白质组学分析预测CBD影响的靶通路。
主要发现
- CBD在正常培养条件下对hDPSC行为影响极小。
- 1.25 μg/mL CBD可显著促进LPS处理条件下的细胞增殖并恢复hDPSC的成牙/成骨分化潜能。
- 蛋白质组学分析显示CBD暴露后CCL8、CDC42和KFL5等参与细胞增殖和分化的蛋白上调。
- RNA测序数据显示CBD上调Notch信号通路。
- Notch抑制剂DAPT可减弱CBD对LPS抑制的hDPSC矿化的恢复作用。
临床怎么用
- CBD可能作为炎症条件下促进牙本质再生的潜在治疗选项。
- 1.25 μg/mL为体外实验中逆转LPS抑制作用的最适浓度。
- Notch信号通路可能是CBD发挥作用的靶点。
局限性
- 研究为体外细胞实验,结果需进一步体内验证。
- 样本来源为人类牙髓组织,但未报告样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Cannabidiol (CBD), derived from the Cannabis sativa plant, exhibits benefits in potentially alleviating a number of oral and dental pathoses, including pulpitis and periodontal diseases. This study aimed to explore the impact of CBD on several traits of human dental pulp stem cells (hDPSC), such as their proliferation, apoptosis, migration and odonto/osteogenic differentiation. METHODOLOGY: hDPSCs were harvested from human dental pulp tissues. The cells were treated with CBD at concentrations of 1.25, 2.5, 5, 10, 25 and 50 μg/mL. Cell responses in terms of cell proliferation, colony-forming unit, cell cycle progression, cell migration, apoptosis and odonto/osteogenic differentiation of hDPSCs were assessed in the normal culture condition and P. gingivalis lipopolysaccharide (LPS)-induced 'inflammatory' milieus. RNA sequencing and proteomic analysis were performed to predict target pathways impacted by CBD. RESULTS: CBD minimally affects hDPSCs' behaviour under normal culture growth milieu in normal conditions. However, an optimal concentration of 1.25 μg/mL CBD significantly countered the harmful effects of LPS, indicated by the promoting cell proliferation and restoring the odonto/osteogenic differentiation potential of hDPSCs under LPS-treated conditions. The proteomic analysis demonstrated that several proteins involved in cell proliferation and differentiation were upregulated following CBD exposure, including CCL8, CDC42 and KFL5. RNA sequencing data indicated that CBD upregulated the Notch signalling pathway. In an inhibitory experiment, DAPT, a Notch inhibitor, reduced the effect of CBD-rescued LPS-attenuated mineralization in hDPSCs, suggesting that CBD potentially mediates Notch activation to exert its impact on odonto/osteogenic differentiation of hDPSCs. CONCLUSIONS: CBD recovers the proliferation and survival of hDPSCs following exposure to LPS. Additionally, we report that CBD-mediated Notch activation effectively restores the odonto/osteogenic differentiation ability of hDPSCs under inflamed conditions. These results underscore the potential role of CBD as a therapeutic option to enhance dentine regeneration.
引用
- Kornsuthisopon C, Chansaenroj A, Suwittayarak R, et al. Cannabidiol alleviates LPS-inhibited odonto/osteogenic differentiation in human dental pulp stem cells in vitro. Int Endod J. 2024. PMID: 39697062. doi:10.1111/iej.14183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。